Clin2
NCT06985537Likely a fitNot yet recruiting

Steroid Injection for Breast Inflammation (IGM)

Idiopathic Granulomatous Mastitis

Part of Immune system & allergy clinical trials.

This trial tests whether a steroid injection directly into the breast can help treat idiopathic granulomatous mastitis (IGM), a rare non-cancerous inflammatory breast condition. If you have been diagnosed with IGM, this study offers a potentially less invasive treatment option.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
40 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • You must be a woman diagnosed with idiopathic granulomatous mastitis (IGM) by both a clinical exam and a biopsy.
  • You need to be willing to receive steroid injections directly into the breast tissue.
  • You must not have any active infections (like a skin infection or abscess).
  • You should not be taking medications that suppress your immune system (e.g., steroids, chemotherapy, or biologics).
  • You cannot be pregnant.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06943482Not yet recruiting· Phase 4
Comparing steroids vs methotrexate for chronic breast inflammation

This trial compares two treatments—steroids (prednisolone) and methotrexate—for a chronic inflammatory breast condition. It aims to find which option works better with fewer side effects.

Singapore
NCT07422870Not yet recruiting
Registry for granulomatous mastitis

This study is creating a registry (a database) for people with a rare inflammatory breast condition called granulomatous mastitis. It aims to learn more about the disease and how it affects people, without testing any new treatments.

Düsseldorf, North Rhine-Westphalia
NCT07454772Not yet recruiting· Phase 1/Phase 2
Antibiotics vs steroids for granulomatous lobular mastitis

This study compares two common treatments—antibiotics and steroids—to see which works better for a rare breast inflammation condition called granulomatous lobular mastitis (GLM). It aims to find the most effective and safe option for women with this condition.

Bhubaneswar, Odisha
NCT07595900Not yet recruiting· Phase 1/Phase 2
Tocilizumab for Hard-to-Treat Breast Inflammation

This trial tests tocilizumab, a medication that reduces inflammation, for granulomatous lobular mastitis (GLM)—a rare, persistent breast inflammation. If your GLM hasn't responded to steroid therapy or you can't tolerate steroids, this study may help reduce inflammation and symptoms.

NCT06565845Recruiting
Comparing treatments for granulomatous lobular mastitis

This study looks at different ways to treat granulomatous lobular mastitis (GLM), a type of breast inflammation that is not an infection. The goal is to find which treatment works best for people with this condition.

Harbin, Heilongjiang
NCT05395949Enrolling by invitation
Treat breast inflammation with support for mental health

This study looks at a non-surgical (“conservative”) approach to treating granulomatous lobular mastitis, along with help for mental health symptoms. It may help people whose breast inflammation and mental health concerns happen together.

Wuhan, Hubei

Hear when a new Idiopathic Granulomatous Mastitis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.